Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 20, Issue -, Pages 95-101Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2014.12.001
Keywords
-
Categories
Funding
- Agence Nationale de la Recherche [ANR-09-PIRI-0011, ANR-09BIOT-018, ANR-13-BSV5-0007]
- FRM (Equipe FRM) [DEQ20130326522]
- Fondation Bettencourt Schueller
- Agence Nationale de la Recherche (ANR) [ANR-13-BSV5-0007, ANR-09-PIRI-0011] Funding Source: Agence Nationale de la Recherche (ANR)
Ask authors/readers for more resources
The metabotropic glutamate receptors (mGluRs) are glutamate-activated G protein-coupled receptors widely expressed in the central nervous system. The eight mGluRs subtypes modulate transmission at many synapses, and are interesting therapeutic targets for the treatment of many neurological and psychiatric diseases. In particular, their organization in multiple domains and subunits offers various possibilities for the development of drugs that modulate mGluRs activity with different efficacies. Recent structural, biophysical and functional analyses have provided new insights into the mechanism of mGluR activation and dynamics. They also revealed the structural bases of ligand efficacy then providing possible mechanism of action of partial agonists and allosteric modulators. These new findings are of great interest for the development of novel mGluR subtype-selective compounds.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available